• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Predictive ability of longitudinal changes in PRECISE-DAPT score in patients on dual antiplatelet therapy: The RE-SCORE multicentre prospective registry.

作者信息

Pelliccia Francesco, Pasceri Vincenzo, Marazzi Giuseppe, Cacciotti Luca, Placanica Attilio, Gragnano Felice, Niccoli Giampaolo, Palmerini Tullio, Tanzilli Gaetano, Speciale Giulio, Granatelli Antonino, Calabrò Paolo, Crea Filippo, Gaudio Carlo

机构信息

Department of Cardiovascular Sciences, Sapienza University, Rome, Italy.

Interventional Cardiology, San Filippo Neri Hospital, Rome, Italy.

出版信息

Eur J Prev Cardiol. 2021 Oct 13;28(12):e36-e38. doi: 10.1177/2047487320937846. Epub 2020 Jul 5.

DOI:10.1177/2047487320937846
PMID:34647586
Abstract
摘要

相似文献

1
Predictive ability of longitudinal changes in PRECISE-DAPT score in patients on dual antiplatelet therapy: The RE-SCORE multicentre prospective registry.双联抗血小板治疗患者中PRECISE-DAPT评分纵向变化的预测能力：RE-SCORE多中心前瞻性注册研究
Eur J Prev Cardiol. 2021 Oct 13;28(12):e36-e38. doi: 10.1177/2047487320937846. Epub 2020 Jul 5.
2
Gender-related differences in changes of estimated bleeding risk in patients on dual antiplatelet therapy: the RE-SCORE multicenter prospective registry.双联抗血小板治疗患者估计出血风险变化的性别差异：RE-SCORE多中心前瞻性注册研究
Platelets. 2022 Nov 17;33(8):1228-1236. doi: 10.1080/09537104.2022.2102602. Epub 2022 Jul 25.
3
Prediction of Ischemic and Bleeding Events Using the Dual Antiplatelet Therapy Score in an Unrestricted Percutaneous Coronary Intervention Population.在不受限制的经皮冠状动脉介入治疗人群中使用双联抗血小板治疗评分预测缺血和出血事件。
Circ Cardiovasc Interv. 2018 Oct;11(10):e006853. doi: 10.1161/CIRCINTERVENTIONS.118.006853.
4
Clinical Usefulness of PRECISE-DAPT Score for Predicting Bleeding Events in Patients With Acute Coronary Syndrome Undergoing Percutaneous Coronary Intervention: An Analysis From the SMART-DATE Randomized Trial.PRECISE-DAPT 评分预测行经皮冠状动脉介入治疗的急性冠状动脉综合征患者出血事件的临床价值：来自 SMART-DATE 随机试验的分析。
Circ Cardiovasc Interv. 2020 May;13(5):e008530. doi: 10.1161/CIRCINTERVENTIONS.119.008530. Epub 2020 May 1.
5
Bleeding Risk, Dual Antiplatelet Therapy Cessation, and Adverse Events After Percutaneous Coronary Intervention: The PARIS Registry.经皮冠状动脉介入治疗后出血风险、双联抗血小板治疗停药和不良事件：PARIS 注册研究。
Circ Cardiovasc Interv. 2020 Apr;13(4):e008226. doi: 10.1161/CIRCINTERVENTIONS.119.008226. Epub 2020 Mar 27.
6
Validating Utility of Dual Antiplatelet Therapy Score in a Large Pooled Cohort From 3 Japanese Percutaneous Coronary Intervention Studies.验证双联抗血小板治疗评分在来自 3 项日本经皮冠状动脉介入治疗研究的大型汇总队列中的效用。
Circulation. 2018 Feb 6;137(6):551-562. doi: 10.1161/CIRCULATIONAHA.117.028924. Epub 2017 Oct 5.
7
Long versus short dual antiplatelet therapy in acute coronary syndrome patients treated with prasugrel or ticagrelor and coronary revascularization: Insights from the RENAMI registry.接受普拉格雷或替格瑞洛治疗的急性冠脉综合征患者中长程与短程双联抗血小板治疗与冠状动脉血运重建：来自 RENAMI 注册研究的结果。
Eur J Prev Cardiol. 2020 May;27(7):696-705. doi: 10.1177/2047487319836327. Epub 2019 Mar 12.
8
Derivation and validation of the predicting bleeding complications in patients undergoing stent implantation and subsequent dual antiplatelet therapy (PRECISE-DAPT) score: a pooled analysis of individual-patient datasets from clinical trials.经支架植入和随后双联抗血小板治疗（PRECISE-DAPT）的患者预测出血并发症的预测评分的推导和验证：来自临床试验的个体患者数据集的汇总分析。
Lancet. 2017 Mar 11;389(10073):1025-1034. doi: 10.1016/S0140-6736(17)30397-5.
9
Validation of the 4-Item PRECISE-DAPT Score: A SWEDEHEART Study.4 项 PRECISE-DAPT 评分验证：SWEDEHEART 研究。
J Am Heart Assoc. 2021 Oct 19;10(20):e020974. doi: 10.1161/JAHA.121.020974. Epub 2021 Oct 6.
10
A prospective interventional registry of short-term dual-antiplatelet treatment after implantation of drug-eluting stents in patients with atrial fibrillation requiring oral anticoagulation therapy.一项针对需要口服抗凝治疗的房颤患者植入药物洗脱支架后短期双联抗血小板治疗的前瞻性干预性注册研究。
Cardiovasc Interv Ther. 2020 Apr;35(2):150-161. doi: 10.1007/s12928-019-00589-7. Epub 2019 May 15.

引用本文的文献

1
Dual antiplatelet therapy in GI-bleed patients with extensive coronary artery disease history: a systematic review.有广泛冠状动脉疾病史的胃肠道出血患者的双重抗血小板治疗：一项系统评价
Ann Med Surg (Lond). 2025 Apr 25;87(6):3715-3735. doi: 10.1097/MS9.0000000000002833. eCollection 2025 Jun.
2
Feasibility of anticoagulation on demand after percutaneous coronary intervention in high-bleeding risk patients with paroxysmal atrial fibrillation: the INTERMITTENT registry.阵发性心房颤动高出血风险患者经皮冠状动脉介入治疗后按需抗凝的可行性：INTERMITTENT注册研究
Eur Heart J Digit Health. 2024 Jun 25;5(5):637-642. doi: 10.1093/ehjdh/ztae046. eCollection 2024 Sep.
3
Supporting appropriate use of extended dual antiplatelet therapy post-myocardial infarction based on an innovative 12-month ticagrelor virtual service.
基于创新的12个月替格瑞洛虚拟服务，支持心肌梗死后延长双联抗血小板治疗的合理使用。
Front Cardiovasc Med. 2024 Sep 5;11:1399899. doi: 10.3389/fcvm.2024.1399899. eCollection 2024.
4
Should We Use Aspirin or P2Y Inhibitor Monotherapy in Stable Ischemic Heart Disease?稳定性缺血性心脏病患者应使用阿司匹林单药治疗还是 P2Y12 抑制剂单药治疗？
Curr Atheroscler Rep. 2024 Nov;26(11):649-658. doi: 10.1007/s11883-024-01234-2. Epub 2024 Sep 7.
5
Risk Scores of Bleeding Complications in Patients on Dual Antiplatelet Therapy: How to Optimize Identification of Patients at Risk of Bleeding after Percutaneous Coronary Intervention.双联抗血小板治疗患者出血并发症的风险评分：如何优化经皮冠状动脉介入治疗后出血风险患者的识别
J Clin Med. 2022 Jun 21;11(13):3574. doi: 10.3390/jcm11133574.
6
Antiplatelet Therapy for Atherothrombotic Disease in 2022-From Population to Patient-Centered Approaches.2022年动脉粥样硬化血栓形成性疾病的抗血小板治疗——从群体到以患者为中心的方法
Front Cardiovasc Med. 2022 Jan 28;9:805525. doi: 10.3389/fcvm.2022.805525. eCollection 2022.
7
Risk prediction of bleeding and MACCE by PRECISE-DAPT score post-PCI.PCI术后采用PRECISE-DAPT评分对出血和主要不良心血管和脑血管事件进行风险预测。
Int J Cardiol Heart Vasc. 2021 Mar 13;33:100750. doi: 10.1016/j.ijcha.2021.100750. eCollection 2021 Apr.
8
Impact of genetic variants on clinical outcome after percutaneous coronary intervention in elderly patients.老年患者经皮冠状动脉介入治疗后遗传变异对临床结局的影响。
Aging (Albany NY). 2021 Mar 12;13(5):6506-6524. doi: 10.18632/aging.202799.